ID: ALA3276370

Max Phase: Preclinical

Molecular Formula: C17H21NO4

Molecular Weight: 303.36

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  Oc1ccc(OCC(O)CNCCOc2ccccc2)cc1

Standard InChI:  InChI=1S/C17H21NO4/c19-14-6-8-17(9-7-14)22-13-15(20)12-18-10-11-21-16-4-2-1-3-5-16/h1-9,15,18-20H,10-13H2

Standard InChI Key:  VSXJUNJARXFZBK-UHFFFAOYSA-N

Associated Targets(non-human)

Felis catus 3858 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 303.36Molecular Weight (Monoisotopic): 303.1471AlogP: 1.80#Rotatable Bonds: 9
Polar Surface Area: 70.95Molecular Species: BASEHBA: 5HBD: 3
#RO5 Violations: 0HBA (Lipinski): 5HBD (Lipinski): 3#RO5 Violations (Lipinski): 0
CX Acidic pKa: 9.95CX Basic pKa: 8.74CX LogP: 1.91CX LogD: 0.78
Aromatic Rings: 2Heavy Atoms: 22QED Weighted: 0.62Np Likeness Score: -0.35

References

1. Smith LH, Tucker H..  (1977)  beta-Adrenergic blocking agents. 17. 1-Phenoxy-3-phenoxyalkylamino-2-propanols and 1-alkoxyalkylamino-3-phenoxy-2-propanols.,  20  (12): [PMID:22750] [10.1021/jm00222a022]

Source